Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandell

Showing results (371-380 of 381) with videos related to

Pageof 39
Sort By:
Journal of the Autonomic Nervous System|August 8, 1998
Tritiated-naloxone binding to brainstem opioid receptors in the sudden infant death syndromeH C Kinney, J J Filiano, S F Assmann, et al.
Journal of Neuropathology and Experimental Neurology|July 11, 2000
Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndromeA Panigrahy, J Filiano, L A Sleeper, et al.
Annals of Transplantation|April 15, 2020
A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney TransplantationJustin W Li, Marissa Suh, Mark D Brigham, et al.
Molecular Therapy. Nucleic Acids|February 20, 2025
CleanCap M6 inhibits decapping of exogenously delivered IVT mRNAZachary F Mandell, Andrew Ujita, Jordana Henderson, et al.
Nucleic Acids Research|June 14, 2022
Expression of Bacillus subtilis ABCF antibiotic resistance factor VmlR is regulated by RNA polymerase pausing, transcription attenuation, translation attenuation and (p)ppGppHiraku Takada, Zachary F Mandell, Helen Yakhnin, et al.
Transplantation Proceedings|November 18, 2019
Prevalence of Gout in the Surviving United States Solid Organ Transplantation PopulationMark D Brigham, Andrew Milgroom, Mara Onita Lenco, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|March 27, 2020
Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation PopulationMark D Brigham, Andrew Milgroom, Mara Onita Lenco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline dataJ A Cohen, P A Calabresi, S Chakraborty, et al.
Neurology|February 11, 2009
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MSJ A Cohen, P B Imrey, P A Calabresi, et al.
The Journal of Rheumatology|February 19, 2013
A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteriaRebecca L Prowse, Nicola Dalbeth, Arthur Kavanaugh, et al.
Pageof 39

Showing results (371-380 of 381) with videos related to

Sort By:
Pageof 39
Journal of the Autonomic Nervous System|August 8, 1998
Tritiated-naloxone binding to brainstem opioid receptors in the sudden infant death syndromeH C Kinney, J J Filiano, S F Assmann, et al.
Journal of Neuropathology and Experimental Neurology|July 11, 2000
Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndromeA Panigrahy, J Filiano, L A Sleeper, et al.
Annals of Transplantation|April 15, 2020
A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney TransplantationJustin W Li, Marissa Suh, Mark D Brigham, et al.
Molecular Therapy. Nucleic Acids|February 20, 2025
CleanCap M6 inhibits decapping of exogenously delivered IVT mRNAZachary F Mandell, Andrew Ujita, Jordana Henderson, et al.
Nucleic Acids Research|June 14, 2022
Expression of Bacillus subtilis ABCF antibiotic resistance factor VmlR is regulated by RNA polymerase pausing, transcription attenuation, translation attenuation and (p)ppGppHiraku Takada, Zachary F Mandell, Helen Yakhnin, et al.
Transplantation Proceedings|November 18, 2019
Prevalence of Gout in the Surviving United States Solid Organ Transplantation PopulationMark D Brigham, Andrew Milgroom, Mara Onita Lenco, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|March 27, 2020
Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation PopulationMark D Brigham, Andrew Milgroom, Mara Onita Lenco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline dataJ A Cohen, P A Calabresi, S Chakraborty, et al.
Neurology|February 11, 2009
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MSJ A Cohen, P B Imrey, P A Calabresi, et al.
The Journal of Rheumatology|February 19, 2013
A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteriaRebecca L Prowse, Nicola Dalbeth, Arthur Kavanaugh, et al.
Pageof 39